发明名称 |
Formulations comprising methylthioninium chloride |
摘要 |
Solid dosage forms of methylthioninium chloride (MTC) further comprise at least one diluent suitable for direct compression. The MTC exists in a substantially pure and stable polymorphic form. The solid dosage forms may preferably be prepared by direct compression methods. |
申请公布号 |
US9192611(B2) |
申请公布日期 |
2015.11.24 |
申请号 |
US201113989953 |
申请日期 |
2011.11.30 |
申请人 |
WisTa Laboratories Ltd. |
发明人 |
Khan Karrar Ahmad |
分类号 |
A61K31/5415;A61K9/16;A61K9/20;A61K9/48;C07D279/18 |
主分类号 |
A61K31/5415 |
代理机构 |
Foley & Lardner LLP |
代理人 |
Foley & Lardner LLP |
主权项 |
1. A tablet pharmaceutical composition in solid dosage form comprising:
(a) substantially pure and stable polymorph Form A methylthioninium chloride (“MTC”), (b) at least one diluent suitable for direct compression selected from microcrystalline cellulose or a sugar, (c) optionally further comprising a coating and (d) optionally one or more other excipients, wherein the amount of MTC in the composition is 10-75% w/w of the weight of composition without the coating, and wherein the composition is obtained by a process comprising dry compression of an intimate powder mixture of the MTC in a substantially pure polymorphic form with the at least one diluent suitable for direct compression. |
地址 |
Singapore SG |